| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 2592 |
|---|
| 5 | 5 | | To require the Administrator of the Federal Aviation Administration to pub- |
|---|
| 6 | 6 | | lish the list of medications that the Administrator has compiled for |
|---|
| 7 | 7 | | purposes of the medical certification of airmen, and for other purposes. |
|---|
| 8 | 8 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 9 | 9 | | APRIL2, 2025 |
|---|
| 10 | 10 | | Mr. C |
|---|
| 11 | 11 | | ASTEN(for himself and Mr. STAUBER) introduced the following bill; |
|---|
| 12 | 12 | | which was referred to the Committee on Transportation and Infrastructure |
|---|
| 13 | 13 | | A BILL |
|---|
| 14 | 14 | | To require the Administrator of the Federal Aviation Admin- |
|---|
| 15 | 15 | | istration to publish the list of medications that the Ad- |
|---|
| 16 | 16 | | ministrator has compiled for purposes of the medical |
|---|
| 17 | 17 | | certification of airmen, and for other purposes. |
|---|
| 18 | 18 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 19 | 19 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 20 | 20 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 21 | 21 | | This Act may be cited as the ‘‘Aviation Medication 4 |
|---|
| 22 | 22 | | Transparency Act of 2025’’. 5 |
|---|
| 23 | 23 | | SEC. 2. LIST OF APPROVED MEDICATIONS. 6 |
|---|
| 24 | 24 | | (a) I |
|---|
| 25 | 25 | | NGENERAL.—Not later than 1 year after the 7 |
|---|
| 26 | 26 | | date of enactment of this Act, the Administrator of the 8 |
|---|
| 27 | 27 | | VerDate Sep 11 2014 22:28 Apr 07, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2592.IH H2592 |
|---|
| 28 | 28 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 29 | 29 | | •HR 2592 IH |
|---|
| 30 | 30 | | Federal Aviation Administration shall publish and main-1 |
|---|
| 31 | 31 | | tain on a publicly available website of the Administration 2 |
|---|
| 32 | 32 | | the list of medications and treatments that may be safely 3 |
|---|
| 33 | 33 | | prescribed to an airman to treat certain medical conditions 4 |
|---|
| 34 | 34 | | that the Administrator has compiled for purposes of the 5 |
|---|
| 35 | 35 | | issuance of a medical certification to an airman. 6 |
|---|
| 36 | 36 | | (b) R |
|---|
| 37 | 37 | | EQUIREMENTS.—The list required under sub-7 |
|---|
| 38 | 38 | | section (a) shall— 8 |
|---|
| 39 | 39 | | (1) be drafted in consultation with— 9 |
|---|
| 40 | 40 | | (A) the Aeromedical Innovation and Mod-10 |
|---|
| 41 | 41 | | ernization Working Group; 11 |
|---|
| 42 | 42 | | (B) the certified exclusive bargaining rep-12 |
|---|
| 43 | 43 | | resentatives of air traffic controllers of the Ad-13 |
|---|
| 44 | 44 | | ministration certified under section 7111 of 14 |
|---|
| 45 | 45 | | title 5, United States Code; 15 |
|---|
| 46 | 46 | | (C) the principal organization representing 16 |
|---|
| 47 | 47 | | the largest certified collective bargaining rep-17 |
|---|
| 48 | 48 | | resentative of airline pilots; and 18 |
|---|
| 49 | 49 | | (D) any other stakeholder determined rel-19 |
|---|
| 50 | 50 | | evant by the task group, including any stake-20 |
|---|
| 51 | 51 | | holders described in section 411(d)(3)(B) of the 21 |
|---|
| 52 | 52 | | FAA Reauthorization Act of 2024; 22 |
|---|
| 53 | 53 | | (2) be comprehensive; 23 |
|---|
| 54 | 54 | | (3) be drafted in a user-friendly and accessible 24 |
|---|
| 55 | 55 | | manner and provided to airmen at the time when 25 |
|---|
| 56 | 56 | | VerDate Sep 11 2014 22:28 Apr 07, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H2592.IH H2592 |
|---|
| 57 | 57 | | ssavage on LAPJG3WLY3PROD with BILLS 3 |
|---|
| 58 | 58 | | •HR 2592 IH |
|---|
| 59 | 59 | | such airmen first seek a license and medical certifi-1 |
|---|
| 60 | 60 | | cation; 2 |
|---|
| 61 | 61 | | (4) indicate what, if any, period of time, on av-3 |
|---|
| 62 | 62 | | erage, an airman must have limited or no duties to 4 |
|---|
| 63 | 63 | | stabilize on an approved medication; 5 |
|---|
| 64 | 64 | | (5) include the list of medications that the Ad-6 |
|---|
| 65 | 65 | | ministrator has designated as ‘‘Do Not Issue’’; 7 |
|---|
| 66 | 66 | | (6) include a mechanism for doctors or medical 8 |
|---|
| 67 | 67 | | providers to contact the Federal Aviation Adminis-9 |
|---|
| 68 | 68 | | tration regarding questions related to such list; 10 |
|---|
| 69 | 69 | | (7) include any additional information that the 11 |
|---|
| 70 | 70 | | Administrator determines is appropriate to provide 12 |
|---|
| 71 | 71 | | with respect to what conditions a certain medication 13 |
|---|
| 72 | 72 | | may or may not be used to treat and any informa-14 |
|---|
| 73 | 73 | | tion to explain why a medication is allowed or pro-15 |
|---|
| 74 | 74 | | hibited by the Federal Aviation Administration; and 16 |
|---|
| 75 | 75 | | (8) include any other information or clarifica-17 |
|---|
| 76 | 76 | | tion that the Administrator determines appropriate. 18 |
|---|
| 77 | 77 | | (c) A |
|---|
| 78 | 78 | | NNUALUPDATE.—Not later than 1 year after 19 |
|---|
| 79 | 79 | | the date of publication of the list required under sub-20 |
|---|
| 80 | 80 | | section (a), and annually thereafter, the Administrator 21 |
|---|
| 81 | 81 | | shall update such list, as appropriate. 22 |
|---|
| 82 | 82 | | Æ |
|---|
| 83 | 83 | | VerDate Sep 11 2014 22:28 Apr 07, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H2592.IH H2592 |
|---|
| 84 | 84 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|